CA2690764A1 - Method for the diagnosis or the screening of an arbovirus infection, reagents useful in said method and their applications - Google Patents

Method for the diagnosis or the screening of an arbovirus infection, reagents useful in said method and their applications Download PDF

Info

Publication number
CA2690764A1
CA2690764A1 CA2690764A CA2690764A CA2690764A1 CA 2690764 A1 CA2690764 A1 CA 2690764A1 CA 2690764 A CA2690764 A CA 2690764A CA 2690764 A CA2690764 A CA 2690764A CA 2690764 A1 CA2690764 A1 CA 2690764A1
Authority
CA
Canada
Prior art keywords
phoa
protein
hybrid protein
hybrid
alkaline phosphatase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2690764A
Other languages
English (en)
French (fr)
Inventor
Hugues Bedouelle
Elodie Brient-Litzler
Philippe Dussart
Philippe Despres
Laetitia Bremand
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Institut Pasteur
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2690764A1 publication Critical patent/CA2690764A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • G01N2333/183—Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus) or border disease virus
    • G01N2333/185—Flaviviruses or Group B arboviruses, e.g. yellow fever virus, japanese encephalitis, tick-borne encephalitis, dengue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA2690764A 2007-06-15 2008-06-13 Method for the diagnosis or the screening of an arbovirus infection, reagents useful in said method and their applications Abandoned CA2690764A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07290749A EP2003144A1 (en) 2007-06-15 2007-06-15 Method for the diagnosis or the screening of an arbovirus infection, reagents useful in said method and their applications
EP07290749.6 2007-06-15
PCT/IB2008/002614 WO2008152528A2 (en) 2007-06-15 2008-06-13 Method for the diagnosis or the screening of an arbovirus infection, reagents useful in said method and their applications

Publications (1)

Publication Number Publication Date
CA2690764A1 true CA2690764A1 (en) 2008-12-18

Family

ID=38740531

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2690764A Abandoned CA2690764A1 (en) 2007-06-15 2008-06-13 Method for the diagnosis or the screening of an arbovirus infection, reagents useful in said method and their applications

Country Status (8)

Country Link
US (1) US8357496B2 (enExample)
EP (2) EP2003144A1 (enExample)
JP (1) JP2010530960A (enExample)
CN (1) CN101784561A (enExample)
AU (1) AU2008263507B2 (enExample)
BR (1) BRPI0814247A2 (enExample)
CA (1) CA2690764A1 (enExample)
WO (1) WO2008152528A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2272860A1 (en) 2009-07-10 2011-01-12 Institut Pasteur Multivalent epitope in complex with a detection marker for the early serodiagnosis of infections
WO2011026139A1 (en) 2009-08-31 2011-03-03 Gen-Probe Incorporated Dengue virus assay
KR102339120B1 (ko) * 2012-09-27 2021-12-14 아이덱스 래보러토리즈, 인코포레이티드 슈말렌베르그 바이러스(sbv)의 검출 방법 및 키트
JP5866715B2 (ja) 2013-10-18 2016-02-17 国立大学法人九州大学 タンパク質検出用融合タンパク質およびタンパク質の検出方法
EP3465206B1 (en) 2016-06-06 2019-12-04 Medizinische Universität Wien Method for the detection of an igm antibody specific for a flavivius in a sample
EP3558353A2 (en) * 2016-12-23 2019-10-30 Expres2ion Biotechnologies ApS New flavivirus vaccine
GB201704126D0 (en) * 2017-03-15 2017-04-26 Blom Nihlén Kim Andrea Vaccine
KR102832926B1 (ko) * 2017-04-26 2025-07-10 에프. 호프만-라 로슈 아게 가용성 및 면역반응성 지카 바이러스 ns1 폴리펩티드
CN108486219B (zh) * 2018-03-28 2022-02-25 中国人民解放军军事科学院军事医学研究院 一种检测离体血清样本是否感染乙型脑炎病毒的试剂盒

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0688364A4 (en) * 1993-03-09 1997-10-15 Abbott Lab ENZYMES PRODUCED BY GENETIC ENGINEERING AND CONJUGATES OF SAID ENZYMES FOR DIAGNOSTIC ANALYSIS
FR2736065B1 (fr) * 1995-06-29 1997-09-19 Commissariat Energie Atomique Phosphatases alcalines bacteriennes modifiees et leurs applications.
US7227011B2 (en) * 1998-06-04 2007-06-05 United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Nucleic acid vaccines for prevention of flavivirus infection
WO2004016586A2 (en) * 2002-08-16 2004-02-26 Board Of Regents The University Of Texas System Compositions and methods related to flavivirus envelope protein domain iii antigens
DE602005025647D1 (de) * 2004-07-23 2011-02-10 Novartis Vaccines & Diagnostic Polypeptide für die oligomerisierung von antigenen

Also Published As

Publication number Publication date
EP2003144A1 (en) 2008-12-17
WO2008152528A3 (en) 2009-03-12
CN101784561A (zh) 2010-07-21
BRPI0814247A2 (pt) 2015-01-06
EP2170936A2 (en) 2010-04-07
WO2008152528A2 (en) 2008-12-18
JP2010530960A (ja) 2010-09-16
US20100291586A1 (en) 2010-11-18
AU2008263507B2 (en) 2013-09-12
AU2008263507A1 (en) 2008-12-18
US8357496B2 (en) 2013-01-22

Similar Documents

Publication Publication Date Title
AU2008263507B2 (en) Method for the diagnosis or the screening of an arbovirus infection, reagents useful in said method and their applications
EP2272860A1 (en) Multivalent epitope in complex with a detection marker for the early serodiagnosis of infections
Shi et al. Serologic diagnosis of West Nile virus infection
Gaspar-Castillo et al. Structural and immunological basis of cross-reactivity between dengue and Zika infections: Implications in serosurveillance in endemic regions
AnandaRao et al. A custom-designed recombinant multiepitope protein as a dengue diagnostic reagent
JP2023036749A (ja) 可溶性および免疫反応性のフラビウイルスｎｓ１ポリペプチド
Kim et al. Development of a rapid diagnostic test kit to detect IgG/IgM antibody against Zika virus using monoclonal antibodies to the envelope and non-structural protein 1 of the virus
US10955414B2 (en) Immunoassay methods and compositions for detecting infection involving use of test antigens as cross-reactive control antigens
US20240302369A1 (en) System and methods for detection of pathogenic viruses
JP6908299B2 (ja) サンプル中のフラビウイルスに特異的なＩｇＭ抗体の検出方法
Lazaro-Olan et al. Analysis of antibody response in human dengue patients from the Mexican coast using recombinant antigens
Kim et al. Optimization of Zika virus envelope protein production for ELISA and correlation of antibody titers with virus neutralization in Mexican patients from an arbovirus endemic region
Niu et al. Dengue virus envelope domain III protein based on a tetravalent antigen secreted from insect cells: Potential use for serological diagnosis
EP1745291B1 (en) Detection of west nile virus
WO2007034507A2 (en) Tetravalent dengue specific domain iii based chimeric recombinant protein
Ludolfs et al. Reverse ELISA for the detection of anti West Nile virus IgG antibodies in humans
WO2005014627A1 (en) Recombinant dengue multi epitope proteins as diagnostic intermediates
Malnero et al. Expression of recombinant dengue virus type 1 non-structural protein 1 in mammalian cells and preliminary assessment of its suitability to detect human IgG antibodies elicited by viral infection
US10921323B2 (en) Method for the immunological diagnosis of a sample with a potential infection with an arbovirus and test kits suitable for this purpose
CA3205485A1 (en) System and method for rapid and sensitive detection of anti-pathogen antibodies
Kim et al. Temperature-dependent secretion of Zika virus envelope and non-structural protein 1 in mammalian cells for clinical applications
Ma et al. Development of a sensitive sandwich ELISA for the envelope domain III protein of dengue virus type 2
Lebani Antibody discovery for development of a serotyping dengue virus NS1 capture assay
Eltzov et al. Dengue virus diagnostics
Ganguly Ultrasensitive Point-of-Care Dengue Diagnostics and Vaccine Applications

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20130604

FZDE Dead

Effective date: 20160506